Latest news

Clinical

Altimmune Reports Phase 2 Pemvidutide Results in Alcohol Use Disorder

Altimmune has reported topline results from its Phase 2 RECLAIM trial evaluating pemvidutide, an investigational dual GLP-1/GIP receptor agonist,...
Commercial

Included Health Agrees to Acquire Firefly Health to Expand Employer Health Plan Alternatives

Virtual care and health navigation company Included Health has agreed to acquire Firefly Health as it seeks to scale...
Insights

The Workforce Challenge Facing Biopharma Manufacturing

Executive Summary Biopharmaceutical manufacturing is entering one of the most important periods of transformation in its history. Demand for advanced therapies,...
Commercial

Argenx purchases Forte for $2.2 billion to enter the hands-on phase two-stage medication for vitiligo

Forte Biosciences is being acquired by Argenx for $2.2 billion in a deal that has two stages: phase 2...
Regulatory

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Takeda has secured approval from the Drug Controller General...
Commercial

Tempus purchases a specialist in cancer genomics in a $1.5 billion deal: Personalis

Since the two first joined forces in oncology three...
Insights

How RNA Therapeutics Are Expanding Beyond Rare Diseases

Executive Summary RNA therapeutics have emerged as one of the most significant innovations in modern medicine. Initially developed to address rare...
Commercial

Samsung Biologics Plans $1.8 Billion Acquisition of PolyPeptide

Samsung Biologics has announced plans to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide in a transaction valued...
Clinical

Sanofi Ends Amlitelimab Development in Atopic Dermatitis After Phase 3 Program Review

Sanofi has decided to stop pursuing amlitelimab for atopic dermatitis (AD), ending plans to seek regulatory approval for the...
Regulatory

Amgen Submits FDA Hearing Request to Defend Tavneos for ANCA-Associated Vasculitis

Amgen has submitted a package of data and analyses...
Clinical

J&J’s Bispecific Combination Works Wonders on Myeloma Progression in Phase 3 Study

Johnson & Johnson has reported striking Phase 3 results...
Uncategorized

Top 10 Reasons Drug Development Timelines Remain Difficult to Compress

Executive Summary The pharmaceutical industry has made remarkable advances in accelerating drug development. Artificial intelligence (AI), decentralized clinical trials, real-world...
Insights

The Future of AI-Assisted Clinical Operations

Executive Summary Clinical operations sits at the heart of every successful clinical trial. The function is responsible for translating study protocols...
Commercial

BeOne Invests $300 Million to Add Small Molecule Manufacturing at New Jersey Campus

BeOne Medicines has announced a $300 million expansion of its manufacturing and research campus at the Princeton West Innovation...
Regulatory

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Takeda has secured approval from the Drug Controller General...
Editorial Team -
Commercial

Sanofi Deepens Autoimmune Push with $1.8B AI Biotech Deal

Sanofi’s ambition to become a dominant force in immunology...
Commercial

GSK Signs $12 Billion Licensing Deal with Hengrui Pharma for Up to 12 Therapeutic Programs

GSK has signed a licensing agreement with China-based Hengrui...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Regulatory

Regulatory

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Takeda has secured approval from the Drug Controller General...
Editorial Team -
Commercial

Included Health Agrees to Acquire Firefly Health to Expand Employer Health Plan Alternatives

Virtual care and health navigation company Included Health has...
Insights

The Workforce Challenge Facing Biopharma Manufacturing

Executive Summary Biopharmaceutical manufacturing is entering one of the most...
Commercial

Argenx purchases Forte for $2.2 billion to enter the hands-on phase two-stage medication for vitiligo

Forte Biosciences is being acquired by Argenx for $2.2...
Insights

What Pharma Leaders Are Prioritizing in 2026

Executive Summary The pharmaceutical industry is entering a new phase...

Research & Development

Market Access

Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Altimmune Reports Phase 2 Pemvidutide Results in Alcohol Use Disorder

Altimmune has reported topline results from its Phase 2...
Editorial Team -
Insights

The Workforce Challenge Facing Biopharma Manufacturing

Executive Summary Biopharmaceutical manufacturing is entering one of the most...
Editorial Team -